EP0336960A1 - Detoxifying food supplement - Google Patents

Detoxifying food supplement

Info

Publication number
EP0336960A1
EP0336960A1 EP88910286A EP88910286A EP0336960A1 EP 0336960 A1 EP0336960 A1 EP 0336960A1 EP 88910286 A EP88910286 A EP 88910286A EP 88910286 A EP88910286 A EP 88910286A EP 0336960 A1 EP0336960 A1 EP 0336960A1
Authority
EP
European Patent Office
Prior art keywords
acid
sugar
lyxose
fucose
arabitol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP88910286A
Other languages
German (de)
French (fr)
Other versions
EP0336960A4 (en
Inventor
Joseph A. Haklitch
Albert T. Naito
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of EP0336960A1 publication Critical patent/EP0336960A1/en
Publication of EP0336960A4 publication Critical patent/EP0336960A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004Monosaccharides having only carbon, hydrogen and oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Seasonings (AREA)

Abstract

A food additive which has the effect of ameliorating the effects of the ingestion of alcoholic beverages includes the combination of any one or more sugars from the group consisting of zylitol, D(+) galactose, D(+) lactose, D(+) xylose, dulcitol, wyo-insoitol, L(-) fructose, D(-) mannitol, sorbitol, D(+) glucose, D(+) arabinose, D(-) arabinose, celloboise, D(+) maltose, D(+) raffinose, L(+) rhamnose, D(+) melibiose, D(-) ribose, adonitol, D(+) arabitol, L(-) arabitol, D(+) fucose, L(-) fucose, D(-) lyxose, L(+) lyxose, and L(-) lyxose, and any one or more amino acids from the group consisting of arginine, glutamine, lysine, asparagine, aspartic acid, cysteine, glutamic acid, glycine, histidine, leucine, methionine, phenylalamine, proline, serine, threonine, tryptophan, tyrosine, valine, and taurine in a quantity such that for each mea­ sure of the sugar between 2.5 and 6 grams there is a cumulative amount of amino acid which falls within the effective range of at least one of the amino acids in the combination where the effective range in the case of arginine, asparagine, aspartic acid, cysteine, glutamic acid, serine, glycine, histidine, leucine, methionine, phelnylalanine, proline, valine, glutamine, ly­ sine, and taurine is from 25 to 50 milligrams; and, in the case of threonine, tryptophan, and tyrosine, is from 25 to 1500 milligrams. To accelerate the volatilization process, acetic acid or acetylsalicylic acid, or both, is added.

Description

DETOXIFYING FOOD SUPPLEMENT
This invention relates to food supplements which have the effect of ameliorating the effects of the ingestion of alcoholic beverages.
Background
A search for a cure for morning after "hangovers" or for a substance to sober up a drunk is likely to lead to a multitude of home remedies. They range from "hair of the dog that bit you" to tomato juice to strong black coffee. The fact that some of these "cures" are often repeated and recommended by those who try them suggests that they do have some beneficial effect and that there is a human mechanism which, if activated, can diminish drunkenness and the discomfort that attends recovery from drunkenness. More methodical searches for sobering and antihangover substances have suggested that sugars and aspirin are useful. United States patent No. 3,584,122 suggests ingestion of 1000 milligrams of fructose to produce sobering in an hour. West German patent No. 2,321,113 appears to recommend a mixture of one-third ascorbic acid, one third D-glucose and one-third of a mixture of Japanese peppermint oil, eucalyptus oil, and aniseed oil as a sobering mixture but does not appear to quantify any result. Summary of the Invention
One object of the invention is to provide a substance, a food supplement, which has a rapid sobering effect or which reduces post drunkenness discomfort or both.
Another object is to provide such a supplement, which is inexpensive to make and use, is readily manufactured and packaged, has long shelf life, and does not have a disagreeable taste.
Another object is to provide such a substance in a form which can be dissolved in readily-available liquids, fruit juice or plain water, so that it can be ingested by an alcohol drinker at the place where he or she has been drinking.
These and other objects and advantages of the invention which will hereinafter appear, are realized by the provision of a food supplement which converts the alcohol in the ingester's stomach into a different substance, which utilizes body chemistry to reduce blood alcohol to carbon dioxide and urea and which crosses the brain-blood barrier to restore neuro- receptor and neuro-transmitter equilibrium. We have discovered a material that provides those results. It detoxifies alcohol in the stomach and blood in thirty minutes or less, and it restores normal motor function and sensory functions in seconds after being ingested. The material that provides those actions is a combination of one or more of four "pure" sugars with one or more of a number of amino acids. The sugars are L-fructose, L-mannitol, L-sorbitol and D(+)glucose. The term "pure" as applied to sugar herein means crystalline purity, 99 percent pure. The requirement for high purity is based upon both a need for purity and the fact that the character of impurities is unknown and some can negate the arabitol, D(+) fucose, L(-) fucose, D(-) lyxose, L(+) lyxose, and L(-) lyxose. The term "pure" as applied to sugar herein means crystalline purity, 99 percent pure. The requirement for high purity is based upon both a need for purity and the fact that the character of impurities is unknown and some can negate the effectiveness of the sugar or the amino acids. The amino acids are gluta ine, lysine, arginine, asparagine, aspartic acid, cysteine, glutamic acid, glycine, histidine, leucine, methionine, phenylalanine, proline, serine, threonine, tryptophan, tyrosine, valine, and taurine. The amino acids may be those found in common foodstuffs such as orange juice, clam chowder, soy bean soup, sheep milk, and others, but for uniform and more predictable result it is preferred that the amino acid be incorporated in pure crystalline form having optical density of 20 degrees or less.
An excessive amount of any of the listed sugars can cause nausea, heat sensation, flushing, and ringing of the ears. The degree of drunkenness to be overcome and the amount required in the practice of the invention depends in part on the amount of alcohol that was ingested. There is a level of alcohol intake below which the drinker does not require the invention. In terms of amount of sugar, that level is about 2.5 grams. More than 6 grams of sugar may produce the adverse side effects listed above and is not required to produce the sobering effect. Thus the range of sugar per serving is about 2.5 to 6 grams. When prepackaged, 2.5 to 3 grams per package is preferred. A drinker who needs more than 3 grams, may be given two packages.
One function of the sugar is to react chemically with alcohol to change it to harmless form. The chemistry and metabolic process involved in that action has been the subject of much study and several papers on the subject are listed in the bibliography below. It appears that the metabolism of alcohol is accelerated by the addition of a quantity of acetic acid or acetylsalicylic acid to the basic combination of sugar and amino acid. For example, acetylsalicylic acid induces the production of the enzymes which convert ethanol to acetaldehyde by stimulating production of alcohol dehydrogenase in the liver in the volatilization reaction:
CH3 CH2 OH + NAD <=> CH3 CHO + NADH.
The acetaldehyde is converted to acetic acid by the stimulation of the enzyme acetaldehyde dehydrogenase.
CH CHO + H2+ NAD -> H+ + CH3 COOH + NAC
The acetic acid is further converted to a (2) carbon metabolite (CO2) by the enzyme carboxylase.
CH3COOH + NADH -> CO2.
The addition of the acetylsalicylic acid apparently produces, by conjugation, an abundance of carbόxylase to accelerate conversion of the acetic acid to CO2. However, the invention is not concerned with the specifics of the process and relies only on the fact the that alcohol in the blood and stomach can be eliminated as a consequence of ingestion of the ingredients of the inventive supplement. The reaction with alcohol which has not left the stomach is described as follows, using fructose as the example:
fructose CQH1.2O6 alcohol CH3 CH2 OH
C H6O5
H2O
H2O
H2O
+
CO2 (Urea) One function of the amino acid, apparently in consort with the sugar because excessive sugar produces the side effects mentioned above, is to overcome the effect of astrocyte cells and to permit the amino acid to dissolve in the lipids that form part of the endothelial cells of capillaries in the brain. In any event, the amino acids are able to cross the blood-brain barrier and to enter the brain, just as alcohol does, where they nullify the effect of alcohol. The specifics of that process are unknown but are sometimes characterized as restoring equilibrium to the neuro-receptors and neuro- transmitters.
The amino acids listed above have been found to be effective in combination with the listed sugars. Amino acids not in that list have not been found to be effective. In terms of quantity required for effectiveness with sugar in the range 2.5 to 6 grams, the amino acids arginine, tryptophan and tyrosine have been found to be effective in the range 25 to 3000 milligrams. The others appear to be effective in the range from 25 to 50 milligrams. The three amino acids which are effective over the greatest range: arginine, tryptophan, and tyrosine, are preferred over the other amino acids. The smaller number represents the minimum amount for reasonable effectiveness, and the upper amount represents the quantity above which the desired effect tends not to be increased. There appears to be no bar, except that the total may be too much or too little, to combining the amino acids that appear in the list above. On the other hand, to add others of the amino acids or other substances may have the effect of frustrating the invention. For example, orange juice, tomato juice, grapefruit juice, apple juice, lemon juice, milk, chicken broth, beef broth, clam and fish soup, high protein powder, and soybean soup all contain amino acids found in the list above. However, grapefruit juice, apple juice, and tomato juice have too little amino acid and tend to nullify or minimize the effectiveness of the invention.
Description of the Preferred Embodiment
In the broad sense, the preferred form of the invention is a combination of any one or more of the listed sugars and any one or more of the listed amino acids in a quantity such that for each measure of the sugar between 2.5 and 6 grams there is an accumulation of effective amounts to a total of about 480 milligrams or more.
In a more specific sense, it is now preferred that the sugar and amino acid combination be provided in powdered rather than in capsule or pill form to minimize the possibility of choking by an inebriated user. Also, it is preferred to incorporate something to flavor the mixture and enhance its palatability. That can be done by adding one or both of an artificial flavoring material and a dried and powdered fruit in crystalline or solid form which has a desired flavor and, in addition, serves as a source of amino acid. Orange and lemon solids or crystals are examples.
No upper limit to the permissible amount of amino acid has been found. However: because of recommendations by medical authorities that persons with certain kinds of ailments avoid ingesting massive doses of amino acid; because among the liquids which are sometimes recommended for medicinal use, sheep milk at 8000 milligrams per cup (240 cc) has the highest amino acid content; and further, because it is recommended according to the invention to ingest the materials of the invention with approximately one cup (240 cσ) of water or fruit juice; it is considered that the upper limit of amino acid to be combined with 6 or less grams of the sugar is 8000 milligrams. The quantity above which additional quantities of amino acids have no effect when combined with 2.5 to 6 grams of sugar is between 2000 and 3000 milligrams. The lower limit for observable beneficial result is very low, five to ten milligrams of amino acid. However, tests indicate that at least 480 milligrams is required to insure restoration of motor and sensory functions to very inebriated subjects. On that basis the preferred range of ingredients is 2.5 to 6 grams of pure form of one or more of the sugars listed above together with 480 to 3000 milligrams of pure, or foodstuff form, of one or more of the amino acids listed above. Within the list of amino acids, arginine, tryptophan, and tyrosine are preferred.
Examples
Example 1. The combination of 3 grams of pure sugar selected from, or consisting of a combination of sugars from, the group consisting of zylitol, D(+) galactose, D(+) lactose, D(+) xylose, dulcitol, wyo-insoitol, L(-) fructose, D(-) mannitol, sorbitol, D(+) glucose, D(+) arabinose, D(-) arabinose, celloboise, D(+) maltose, D(+) raffinose, L(+)rhamnose, D(+) melibiose, D(-) ribose, adonitol, D(+) arabitol, L(-) arabitol, D(+) fucose, L(-) fucose, D(-) lyxose, L(+) lyxose, and L(-) lyxose with 480 to 3000 milligrams of pure, crystalline amino acid consisting of any combination of, or any one of, the group of amino acids consisting of glutamine, . lysine, arginine, asparagine, aspartic acid, cysteine, glutamic acid, glycine, histidine, leucine, methionine, phenylalanine, proline, serine, threonine, tryptophan, tyrosine, valine, and taurine.
Example 2. The combination of 3 grams of pure sugar selected from, or consisting of a combination of sugars from, the group consisting of zylitol, D(+) galactose, D(+) lactose, D(+) xylose, dulcitol, wyo-insoitol, L(-) fructose, D(-) mannitol. sorbitol, D(+) glucose, D(+) arabinose, D(-) arabinose, celloboise, D(+) maltose, D(+) raffinose, L(+)rhamnose, D(+) elibiose, D(-) ribose, adonitol, D(+) arabitol, L(-) arabitol, D(+) fucose, L(-) fucose, D(-) lyxose, L(+) lyxose, and L(-) lyxose with 480 to 3000 milligrams of pure, crystalline amino acid consisting of any combination of, or any one of, the group of amino acids consisting of arginine, tryptophan, and tyrosine.
Example 3. The combination of 3 grams of pure sugar selected from, or consisting of a combination of sugars from, the group consisting of zylitol, D(+) galactose, D(+) lactose, D(+) xylose, dulcitol, wyo-insoitol, L(-) fructose, D(-) mannitol, sorbitol, D(+) glucose, D(+) arabinose, D(-) arabinose, celloboise, D(+) maltose, D(+) raffinose, L(+)rhamnose, D(+) melibiose, D(-) ribose, adonitol, D(+) arabitol, L(-) arabitol, D(+) fucose, L(-) fucose, D(-) lyxose, L(+) lyxose, and L(-) lyxose with 480 to 1000 milligrams of pure, crystalline amino acid consisting of any combination of, or any one of, the group of amino acids consisting of arginine, tryptophan, tyrosine, and a quantity of an amino acid containing foodstuff in dry solid or in crystalline form containing no more than 7000 milligrams of amino acid.
Example 4. The combination of 3 grams of pure sugar selected from, or consisting of a combination of sugars from, the group consisting of zylitol, D(+) galactose, D(+) lactose, D(+) xylose, dulcitol, wyo-insoitol, L(-) fructose, D(-) mannitol, sorbitol, D(+) glucose, D(+) arabinose, D(-) arabinose, celloboise, D(+) maltose, D(+) raffinose, L(+)rhamnose, D(+) melibiose, D(-) ribose, adonitol, D(+) arabitol, L(-) arabitol, D(+) fucose, L(-) fucose, D(-) lyxose, L(+) lyxose, and L(-) lyxose with a quantity of an amino acid containing foodstuff in dry solid or in crystalline form containing no more than 8000 milligrams of one or more of the amino acids in the group consisting of glutamine, lysine, arginine. asparagine, aspartic acid, cysteine, glutamic acid, glycine, histidine, leucine, methionine, phenylalanine, proline, serine, threonine, tryptophan, tyrosine, valine, and taurine.
Restoration of motor and sensory functions is so rapid that no acceleration is needed. If it is desired to accelerate the metabolism of alcohol, acetylsalicylic acid is added at the rate of about three to six grains for each 2.5 to 3 grams of sugar. Also, the addition of acetylsalicylic acid has the added advantage that the resulting mixture also helps overcome the discomfort that is often experienced while overcoming alcohol intoxication. The addition of the acetylsalicylic acid to the basic mixture of the invention results in a product which is useful as a remedy for the after effects of alcohol intoxication even if ingested after the ingester is no longer intoxicated.
In this modification of the basic recipe, three to six grains of acetylsalicylic acid is added for each 2.5 grams of sugar up to a maximum of 12 grains of the acid. Again, all or a part of the amino acid may be added in the form of a fruit juice or other foodstuff which is rich in one or more of the operative amino acids.
Citric acid is an alternative to acetylsalicylic acid as a potentiator of the volatilization of alcohol. The minimum amount for effectiveness is about ten percent by weight of the amount of sugar. The inclusion of citric acid rather than acetylsalicylic acid has the advantage that the upper permissible limit is established by taste rather than by some deleterious effect.
Acetylsalicylic acid and citric acid may be combined such that the product includes an amount of acetylsalicylic acid which equals approximately 0.025 to 0.06 grains for each milligram in which the amount of acetic acid is less than 100 milligrams per gram of sugar.
Bibliography
Charles S. Lieber, The Metabolism of Alcohol, Scientific American Volume 234, Number 3, March 1976.
U. Sprandel, H.D. Troger, E.W. Liebhardt and N. Zollner,
Acceleration of Ethanol elimination with Fructose in Man Medizinische Poliklinik und Institut Fur Gerichtsmedizin, Universitat Munchen, Munich, accepted December 28, 1975.
Leah M. Lowenstein, Rosemary Simone, Phillip Boulter and Peter Nathan, Effect of Fructose on Alcohol Concentrations in the Blood of Man. JAMA September 14, 1970, Volume 213, Number 11.
Julius Merry and Vincent Marks, Effect on Performance of
Reducing Blood-Alcohol with Oral Fructose. THE LANCET, December 23, 1967.
Richard Levy, Tom Elo and Irwin B. Hanenson, Intravenous Fructose Treatment of Acute Alcohol Intoxication Arch Intern Med, Volume 137, September 1977.
Arun K. Rawat, Effects of Fructose and Other Fructose and Other Substances on Ethanol and Acetaldehyde Metabolism in Man. Research Communications in Chemical Pathology and Pharmacology, Volume 16, Number 2, February 1977.
Brenda P. Crownover, Jeffrey La Dine, Blair Bradford, Edward Glassman, Donald For an, Heinz Schneider, and Ronald G. Thurman, Activation of Ethanol Metabolism in Humans by Fructose: Importance of Experimental Design. The Journal of PharmacologyAnd Experimental Therapeutics, Volume 236, Number 12, 1986.

Claims

The ClaimsWe claim:
1. The combination of any one or more pure sugars from the group consisting of zylitol, D(+) galactose, D(+) lactose, D(+) xylose, dulcitol, wyo-insoitol, L(-) fructose, D(-) mannitol, sorbitol, D(+) glucose, D(+) arabinose, D(-) arabinose, celloboise, D(+) maltose, D(+) raffinose, L(+)rhamnose, D(+) melibiose, D(-) ribose, adonitol, D(+) arabitol, L(-) arabitol, D(+) fucose, L(-) fucose, D(-) lyxose, L(+) lyxose, and L(-) lyxose; and any one or more amino acids from the group consisting of arginine, asparagine, aspartic acid, cysteine, glutamic acid, glycine, histidine, leucine, methionine, phenylalanine, proline, serine, threonine, glutamine, lysine, tryptophan, tyrosine, valine, and taurine in a quantity such that for each measure of the sugar between 2.5 and 6 grams there is a cumulative amount of amino acid which is not less than 480 milligrams.
2. In combination: sugar and amino acid in the proportions 2.5 to 3 grams of sugar from the group zylitol, D(+) galactose, D(+) lactose, D(+) xylose, dulcitol, wyo-insoitol, L(-) fructose, D(-) mannitol, sorbitol, D(+) glucose, D(+) arabinose, D(-) arabinose, celloboise, D(+) maltose, D(+) raffinose, L(+)rhamnose, D(+) melibiose, D(-) ribose, adonitol, D(+) arabitol, L(-) arabitol, D(+) fucose, L(-) fucose, D(-) lyxose, L(+) lyxose, and L(-) lyxose and at least 480 milligrams of one or more of arginine, tryptophan, and tyrosine.
3. An article of manufacture comprising sugar and amino acid in the proportions 2.5 to 3 grams of sugar from the group zylitol, D(+) galactose, D(+) lactose, D(+) xylose, dulcitol, wyo-insoitol, L(-) fructose, D(-) mannitol, sorbitol, D(+) glucose, D(+) arabinose, D(-) arabinose, celloboise, D(+) maltose, D(+) raffinose, L(+)rhamnose, D(+) melibiose, D(-) ribose, adonitol, D(+) arabitol, L(-) arabitol, D(+) fucose, L(-) fucose, D(-) lyxose, L(+) lyxose, and L(-) lyxose mixed and packaged as a dry powder with between 480 and 3000 milligrams of one or more of threonine, tryptophan, and tyrosine.
4. The invention defined in Claim 3 in which said article further comprises a quantity of edible flavoring and coloring material.
5. The invention defined in Claim 2 in which at least a portion of the amino acid is contained in a naturally occurring foodstuff.
6. The invention defined in Claim 1 which further comprises approximately three to six grains of acetylsalicylic acid for each 2.5 to 3 grams of sugar.
7. The invention defined in Claim 2 which further comprises approximately three to six grains of acetylsalicylic acid for each 2.5 to 3 grams of sugar.
8. The invention defined in Claim 3 which further comprises approximately three to six grains of acetylsalicylic acid for each 2.5 to 3 grams of sugar.
9. The method of ameliorating the effects of the ingestion of alcoholic beverages which method comprises ingesting the combination of any one or more sugars from the group consisting of zylitol, D(+) galactose, D(+) lactose, D(+) xylose, dulcitol, wyo-insoitol, L(-) fructose, D(-) mannitol, sorbitol, D(+) glucose, D(+) arabinose, D(-) arabinose, celloboise, D(+) maltose, D(+) raffinose, L(+)rhamnose, D(+) melibiose, D(-) ribose, adonitol, D(+) arabitol, L(-) arabitol, D(+) fucose, L(-) fucose, D(-) lyxose, L(+) lyxose, and L(-) lyxose; and any one or more amino acids from the group consisting of arginine, glutamine, lysine, asparagine, aspartic acid, cysteine, glutamic acid, glycine, histidine, leucine, methionine, phenylalanine, proline, serine, threonine, tryptophan, tyrosine, valine, and taurine in a quantity such that for each measure of the sugar between 2.5 and 6 grams there is a cumulative amount of amino acid which falls within the effective range of at least one of the amino acids in the combination where the effective range in the case of arginine, asparagine, aspartic acid, cysteine, glutamic acid, glycine, histidine, leucine, methionine, phenylalanine, proline, servine, valine, and taurine is from 25 to 50 milligrams, and in the case of threonine, tryptophan, and tyrosine, is from 25 to 1500 milligrams.
10. The invention defined in Claim 9 in which the material to be ingested further comprises approximately three to six grains of acetylsalicylic acid for each 2.5 to 3 grams of sugar.
11. The invention defined in Claim 10 in which at least a portion of said amino acid is contained in a foodstuff.
12. The invention defined in Claim 1 which further comprises approximately one tenth gram of citric acid for each gram of sugar.
13. The invention defined in Claim 9 which further comprises approximately one tenth gram of citric acid for each gram of sugar.
14. The invention defined in Claim 1 which further comprises a quantity of acetic acid and an amount of acetylsalicylic acid which equals approximately 0.025 to 0.06 grains for each milligram in which the amount of acetic acid is less than 100 milligrams per gram of sugar.
15. The invention defined in Claim 11 which further comprises a quantity of acetic acid and an amount of acetylsalicylic acid which equals approximately 0.025 to 0.06 grains for each milligram in which the amount of acetic acid is less than 100 milligrams per gram of sugar.
EP19880910286 1987-10-19 1988-10-13 Detoxifying food supplement. Withdrawn EP0336960A4 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US109597 1980-01-04
US10959787A 1987-10-19 1987-10-19
US23930388A 1988-09-01 1988-09-01
US239303 1988-09-01

Publications (2)

Publication Number Publication Date
EP0336960A1 true EP0336960A1 (en) 1989-10-18
EP0336960A4 EP0336960A4 (en) 1990-02-20

Family

ID=26807138

Family Applications (1)

Application Number Title Priority Date Filing Date
EP19880910286 Withdrawn EP0336960A4 (en) 1987-10-19 1988-10-13 Detoxifying food supplement.

Country Status (2)

Country Link
EP (1) EP0336960A4 (en)
WO (1) WO1989004165A1 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014177989A2 (en) 2013-04-29 2014-11-06 Chigurupati Technologies Private Limited Reduced toxicity in alcoholic beverages
WO2016203499A1 (en) 2015-06-19 2016-12-22 Chigurupati Harsha Synergistic beverage composition

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6294520B1 (en) * 1989-03-27 2001-09-25 Albert T. Naito Material for passage through the blood-brain barrier
GB9215768D0 (en) * 1992-07-24 1992-09-09 Agricultural & Food Res Repression of virulent gene expression
KR970008105B1 (en) * 1993-06-28 1997-05-21 주식회사 미원 Pharmaceutical preparation containing l-aspartate of l-aspara agine for preventing ethanol toxicity and preparation thereof
GB9402950D0 (en) * 1994-02-16 1994-04-06 Univ Leeds Innovations Ltd Sports drink
DE4416429A1 (en) 1994-05-10 1995-11-16 Hoechst Ag Sweetener with an improved sucrose-like taste and process for its production and use
US5798371A (en) * 1995-01-13 1998-08-25 Komissarova; Irina Alexeevna Pharmaceutical composition endowed with an antialcoholic and nootropic effect
GB9715340D0 (en) 1997-07-22 1997-09-24 Cerestar Holding Bv Beverages for enhanced physical performance
DE19755367C2 (en) * 1997-12-12 2001-03-22 Afting Ernst Guenter Pharmaceutical composition containing D-galactose and its use
WO2000071145A1 (en) * 1999-05-24 2000-11-30 Hee Jung Kim Composition for recovering from a hangover and for preventing brain cell damage
RU2191582C2 (en) * 2000-04-05 2002-10-27 Хазанов Вениамин Абрамович Pharmaceutical compositions based on nonsteroid anti-inflammatory agents
JP4754484B2 (en) * 2004-03-18 2011-08-24 田辺三菱製薬株式会社 Depressive symptom improving agent
RU2358723C1 (en) * 2008-01-31 2009-06-20 Андрей Александрович Иващенко Antiwithdrawal agent, biologically active additive, pharmaceutical composition, medical product and method of producing
CA2929338A1 (en) * 2013-11-06 2015-05-14 Salim JARROUJ Composition and method for increasing the rate of alcohol metabolism and preventing hangover symptoms
JP2020531006A (en) 2017-08-18 2020-11-05 カルウッド ニュートリショナルズ,エルエルーシー Compositions and methods for increasing muscle mass and strength, treating the skin, reducing damage and weakness from aging and exposure, and improving recovery from stress such as exercise and trauma.

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0087068A1 (en) * 1982-02-12 1983-08-31 Thomas Moses Dr. Beck Nutritional supplement

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4115572A (en) * 1977-02-03 1978-09-19 American Cyanamid Company Imidazo-[1,5-d]-as-triazin-1(2H)-ones and method of ameliorating asthma
GB1587697A (en) * 1978-02-10 1981-04-08 Honey Bee Corp Acidified beverage of whole milk
US4432975A (en) * 1981-04-13 1984-02-21 Icn Pharmaceuticals, Inc. Process for introducing vitamin B-12 into the bloodstream
US4582705A (en) * 1982-07-12 1986-04-15 Leonard Primes Composition for detoxification
JPS6150917A (en) * 1984-08-20 1986-03-13 Ajinomoto Co Inc Remedying composition for alcoholic hepatopathy
US4647453A (en) * 1984-10-18 1987-03-03 Peritain, Ltd. Treatment for tissue degenerative inflammatory disease
IT1177384B (en) * 1984-12-12 1987-08-26 Boeehringer Biochemia Robin Sp DIETARY GRANULAR PRODUCTS BASED ON AMINO ACIDS AND PROCEDURE FOR THEIR PREPARATION

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0087068A1 (en) * 1982-02-12 1983-08-31 Thomas Moses Dr. Beck Nutritional supplement

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO8904165A1 *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014177989A2 (en) 2013-04-29 2014-11-06 Chigurupati Technologies Private Limited Reduced toxicity in alcoholic beverages
WO2016203499A1 (en) 2015-06-19 2016-12-22 Chigurupati Harsha Synergistic beverage composition
US10456359B2 (en) 2015-06-19 2019-10-29 Harsha Chigurupati Synergistic beverage composition

Also Published As

Publication number Publication date
EP0336960A4 (en) 1990-02-20
WO1989004165A1 (en) 1989-05-18

Similar Documents

Publication Publication Date Title
EP0336960A1 (en) Detoxifying food supplement
EP0448895B1 (en) Use of a non-alcoholic delivery system for active ingredients which are ingested orally
US6406717B2 (en) Rapid-melt semi-solid compositions, methods of making same and methods of using same
US4593020A (en) Therapeutic methods for the treatment of hangover
EP0983726B1 (en) Amino acid-trehalose composition
CA2242646C (en) Amino acid composition
CA2208047A1 (en) Increasing creatine and glycogen concentration in muscle
US5286748A (en) General method of shortening the duration of common colds by application of medicaments to tissues of oral cavity
WO2010118405A2 (en) Compositions and methods for reducing hangover symptoms
JPH03128318A (en) Amino acid composition acting on muscle and nervous system
EP0449787A2 (en) Pharmaceutical, dietetic or veterinary compositions with eumetabolic activity
AU2003268700A1 (en) Amino acid compositions for improving central functions
JPH0352810A (en) Substance passing through blood- brain barrier
JPH05339148A (en) Substance penetrating blood-brain barrier
US6506552B2 (en) Amino acid-trehalose composition
JP3553992B2 (en) Metabolic regulator
JP3228534B2 (en) Composition for lowering blood alcohol concentration
JPH06336432A (en) Adrenaline and noradrenaline secretion promoting composition
FR2635264A1 (en) PHARMACEUTICAL AND / OR DIETARY COMPOSITIONS CONTAINING L-CARNITINE AND L-LYSINE
JP4163801B2 (en) Alcohol metabolism promoting agent
JPH11158075A (en) Pancreatic function regulator
Holder et al. Behavioral assessment of the toxicity of aspartame
JP3380287B2 (en) Beverages that increase blood alcohol levels
JP2001048794A (en) Health food and medicinal composition which contain mixture of powder originated from leaf of mulberry and powder originated from oyster and is used for treating niddm
FR2745981A1 (en) Use of administration of natural or synthetic adsorption agent

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE FR GB IT LI NL SE

17P Request for examination filed

Effective date: 19891115

A4 Supplementary search report drawn up and despatched

Effective date: 19900220

17Q First examination report despatched

Effective date: 19910625

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 19910503